Obesity and Metabolic Disorders

The metabolic syndrome is a condition considered by a special constellation of revocable major risk factors for cardiac disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference.

Obesity is becoming a worldwide epidemic. The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease (CKD). Several recent epidemiologic studies have shown that obesity and the metabolic syndrome are independent predictors of CKD. The prevalence of marked obesity is increasing rapidly among adults and has more than doubled in 10 years. 61% of the adult population of the United States is overweight or obese. 

 

  • Chronic Kidney Disease
  • Cardiovascular Therapy

Related Conference of Obesity and Metabolic Disorders

March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Obesity and Metabolic Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in